Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Novel hemorrhagic shock model reveals time window for intervention

Dec. 4, 2017

Daiichi Sankyo and Translational Sciences terminate TS-23 agreement

Dec. 4, 2017

Afstyla launched in Japan for the treatment of hemophilia A

Dec. 1, 2017

PhaseBio Pharmaceuticals obtains license to ticagrelor reversal agent

Nov. 29, 2017

VE-2851, a promising novel thrombin inhibitor with low bleeding risk

Nov. 28, 2017

FDA grants priority review to Dova's NDA for avatrombopag

Nov. 28, 2017

Pharming submits sBLA for Ruconest for prevention of HAE attacks

Nov. 27, 2017

FDA gives orphan drug status to TRM-201 for hemophilic arthropathy

Nov. 22, 2017

BMS-986141 prevents arterial thrombosis in monkeys

Nov. 22, 2017

Desidustat approved as INN for Zydus Cadila's ZYAN-1

Nov. 22, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...